<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cinnamophilin (CINN, (8R, 8'S)-4, 4'-dihydroxy-3, 3'-dimethoxy-7-oxo-8, 8'-neolignan) protects against <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in mice </plain></SENT>
<SENT sid="1" pm="."><plain>While some anti-oxidative effects of CINN have been characterized, its therapeutic window and molecular basis for neuroprotection remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and anti-inflammatory properties and therapeutic window of CINN against <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> using a panel of in vitro and in vivo assays </plain></SENT>
<SENT sid="3" pm="."><plain>Data from <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and radical scavenging assays showed that CINN was a robust <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and radical scavenger </plain></SENT>
<SENT sid="4" pm="."><plain>CINN effectively inhibited the production of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha), <z:chebi fb="95" ids="16301">nitrite</z:chebi>/nitrate, interleukin-6 (IL-6) in <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS)-stimulated RAW 264.7 and BV2 cells (P&lt;0.05, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Relative to controls, CINN, administrated at 80 mg/kg, 2, 4, or 6 h postinsult, but not 12 h, significantly reduced <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> by 34-43% (P&lt;0.05) and improved neurobehavioral outcome (P&lt;0.05) following transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="6" pm="."><plain>CINN (10-30 microM) also significantly reduced oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation-induced neuronal damage (P&lt;0.05) in rat organotypic hippocampal slices, even when it was administrated 2, 4, or 6 h postinsult </plain></SENT>
<SENT sid="7" pm="."><plain>Together, CINN protects against ischemic brain damage with a therapeutic window up to 6 h in vivo and in vitro, which may, at least in part, be attributed by its direct <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and anti-inflammatory effects </plain></SENT>
</text></document>